Abstract
This editorial outlines the data supporting aggressive lipid goals and options for treating low-density lipoprotein (LDL) cholesterol to a range of approximately 30 to 70 mg/dl. The physiologically normal cholesterol range is approximately 30 to 70 mg/dl for native hunter-gatherers, healthy human neonates, free-living primates, and virtually all wild mammals. Randomized statin trials in patients with recent acute coronary syndromes and stable coronary artery disease have demonstrated that cardiovascular events are reduced and cardiovascular survival optimized when LDL cholesterol is reduced to
| Original language | English |
|---|---|
| Pages (from-to) | 135-139 |
| Number of pages | 5 |
| Journal | American Journal of Cardiology |
| Volume | 98 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jul 1 2006 |
| Externally published | Yes |
Fingerprint
All Science Journal Classification (ASJC) codes
- Cardiology and Cardiovascular Medicine
Cite this
Coronary Artery Disease Prognosis and C-Reactive Protein Levels Improve in Proportion to Percent Lowering of Low-Density Lipoprotein. / O'Keefe, James H.; Cordain, Loren; Jones, Philip G.; Abuissa, Hussam.
In: American Journal of Cardiology, Vol. 98, No. 1, 01.07.2006, p. 135-139.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Coronary Artery Disease Prognosis and C-Reactive Protein Levels Improve in Proportion to Percent Lowering of Low-Density Lipoprotein
AU - O'Keefe, James H.
AU - Cordain, Loren
AU - Jones, Philip G.
AU - Abuissa, Hussam
PY - 2006/7/1
Y1 - 2006/7/1
N2 - This editorial outlines the data supporting aggressive lipid goals and options for treating low-density lipoprotein (LDL) cholesterol to a range of approximately 30 to 70 mg/dl. The physiologically normal cholesterol range is approximately 30 to 70 mg/dl for native hunter-gatherers, healthy human neonates, free-living primates, and virtually all wild mammals. Randomized statin trials in patients with recent acute coronary syndromes and stable coronary artery disease have demonstrated that cardiovascular events are reduced and cardiovascular survival optimized when LDL cholesterol is reduced to
AB - This editorial outlines the data supporting aggressive lipid goals and options for treating low-density lipoprotein (LDL) cholesterol to a range of approximately 30 to 70 mg/dl. The physiologically normal cholesterol range is approximately 30 to 70 mg/dl for native hunter-gatherers, healthy human neonates, free-living primates, and virtually all wild mammals. Randomized statin trials in patients with recent acute coronary syndromes and stable coronary artery disease have demonstrated that cardiovascular events are reduced and cardiovascular survival optimized when LDL cholesterol is reduced to
UR - http://www.scopus.com/inward/record.url?scp=33745161011&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33745161011&partnerID=8YFLogxK
U2 - 10.1016/j.amjcard.2006.01.062
DO - 10.1016/j.amjcard.2006.01.062
M3 - Article
VL - 98
SP - 135
EP - 139
JO - American Journal of Cardiology
JF - American Journal of Cardiology
SN - 0002-9149
IS - 1
ER -